Q1 2022 EPS Estimates for The Beauty Health Company Lifted by Jefferies Financial Group (NASDAQ:SKIN)

The Beauty Health Company (NASDAQ:SKINGet Rating) – Analysts at Jefferies Financial Group lifted their Q1 2022 EPS estimates for Beauty Health in a research report issued on Tuesday, April 26th. Jefferies Financial Group analyst S. Wissink now anticipates that the company will post earnings of $0.00 per share for the quarter, up from their prior estimate of ($0.01). Jefferies Financial Group also issued estimates for Beauty Health’s Q4 2022 earnings at $0.03 EPS, Q1 2023 earnings at $0.02 EPS, Q3 2023 earnings at $0.09 EPS, Q4 2023 earnings at $0.06 EPS and Q1 2024 earnings at $0.02 EPS.

Beauty Health (NASDAQ:SKINGet Rating) last announced its earnings results on Tuesday, February 22nd. The company reported $0.01 EPS for the quarter, beating analysts’ consensus estimates of ($0.03) by $0.04. The business had revenue of $77.90 million for the quarter, compared to the consensus estimate of $70.90 million. The business’s revenue was up 106.1% compared to the same quarter last year.

SKIN has been the topic of a number of other reports. Zacks Investment Research raised Beauty Health from a “hold” rating to a “buy” rating and set a $21.00 price objective on the stock in a research report on Saturday, February 26th. JPMorgan Chase & Co. began coverage on Beauty Health in a research report on Friday, March 11th. They set an “overweight” rating and a $24.00 target price for the company. Piper Sandler decreased their target price on Beauty Health from $31.00 to $26.00 in a research report on Thursday. DA Davidson raised their price objective on Beauty Health from $32.00 to $35.00 and gave the company a “buy” rating in a research report on Wednesday, February 23rd. Finally, Benchmark raised their price target on shares of Beauty Health from $18.00 to $23.00 and gave the stock a “buy” rating in a report on Monday, March 14th. One analyst has rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat.com, Beauty Health has an average rating of “Buy” and an average target price of $27.20.

Shares of NASDAQ SKIN opened at $13.58 on Friday. The firm’s 50 day moving average price is $16.54 and its 200-day moving average price is $20.07. The company has a current ratio of 13.09, a quick ratio of 12.63 and a debt-to-equity ratio of 2.41. Beauty Health has a 52-week low of $10.90 and a 52-week high of $30.17.

A number of institutional investors and hedge funds have recently made changes to their positions in SKIN. PNC Financial Services Group Inc. boosted its position in Beauty Health by 47.5% during the 3rd quarter. PNC Financial Services Group Inc. now owns 1,962 shares of the company’s stock worth $50,000 after buying an additional 632 shares during the period. Baird Financial Group Inc. boosted its holdings in Beauty Health by 3.9% during the fourth quarter. Baird Financial Group Inc. now owns 64,449 shares of the company’s stock worth $1,557,000 after purchasing an additional 2,400 shares during the last quarter. Logan Capital Management Inc. purchased a new position in shares of Beauty Health in the 3rd quarter worth about $78,000. Lindbrook Capital LLC bought a new position in shares of Beauty Health during the 4th quarter worth $74,000. Finally, First Mercantile Trust Co. bought a new position in Beauty Health in the 3rd quarter worth about $82,000. Institutional investors and hedge funds own 62.99% of the company’s stock.

About Beauty Health (Get Rating)

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums.

Further Reading

Earnings History and Estimates for Beauty Health (NASDAQ:SKIN)

Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.